With a J.D/M.B.A from Rutgers University and over 13 years running an award-winning marketing agency, Laurel is uniquely positioned to lead a fund like Fabric. Laurel has worked with more than 200 companies in the CPG and technology spaces, from startups to blue-chip global brands like Facebook, Verizon Digital Media, Geico, PAW Patrol and Zendesk. Her Board of Directors work and extraordinarily networked presence with organizations like Women Founder’s Network, Los Angeles Venture Association, Reuters and Women Business Enterprise National Council provides no shortage of relevant deal flow.

Three exits as CEO, six for companies advised / led on an interim basis. Active in material science and deep tech investing including battery recycle and AI/ML. Two decades of rapid positive results in private and public companies including a rapid transformation of a public company from negative cash flow to GAAP profit (1 year), 3 profitable exits as CEO, an additional 6 exits based on interim CEO / interim / advisor services, and 10’s of Millions USD in funding rounds and strategic deals. Proven leadership approach has been used, applied, and proven from early-stage startup, startup growth phase, restart, and public company turn-around. Key strengths are an ability to identify and communicate the core value of a companies’ offering, create a strategy and operational plan to deliver that value, and lastly, align and lead the existing team(s) to excel in growing revenues rapidly by delivering that value effectively.

Jon heads up VentureRanch, a venture studio emphasizing human connection, stemming from his experience at KOYA, a family-founded company. He served a decade at adidas as their inaugural Innovation Explorer, tapping into 35 years of software expertise, 17 of which focused on location-aware mobile apps. Prior to adidas, Jon founded Bones in Motion in 2003, an innovative mobile software start-up harnessing GPS for real-time fitness experiences; adidas acquired it in 2009. He has diverse experience across consumer electronics, enterprise solutions, and military software. As a software architect for IBM, he relocated his family to Austin, TX, where he remains. Jon boasts over 70 patents, spanning UI design, speech recognition, networking, and mobile fitness.

José serves as the Scientific Director of quadraScope Ventures, a venture capital fund investing in early-stage healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices enabling biological age reversal, disease treatment and prevention. As a physician and molecular biologist, José has performed and published basic and clinical research on several processes involved in aging, including insulin resistance, stem cell differentiation, protein quality control, and cellular energy production. He holds an MD from Universidad Panamericana and a PhD from McGill University.

Mike Maszy is an active angel investor with the Band of Angels where he Chairs their Life Science and MedTech strategic interest group. Most recently he was SVP of Operations for Shockwave Medical. Mike has 23yrs+ experience in medical devices industry including 2 IPOs, multiple acquisitions, Class 3 devices, product design & development, commercialization and extreme scaling.

Jay Goth is a seasoned C-level executive with experience in technology, energy, finance, and healthcare. He is the founder and CEO of Redtail Capital, a strategic management consulting and investing firm. Jay is also the executive director of InSoCal CONNECT, a nonprofit organization formed to support entrepreneurship in inland southern California. He is a member of TCA Venture Group and holds membership in SoCal Bio and OCTANE.

Mo Kagalwala received his Ph.D. in Biochemistry and Molecular Biology from the Southern Illinois University School of Medicine and MBA from UCSD Rady School of Management. Dr. Kagalwala completed postdoctoral fellowships at MD Anderson Cancer Center and the Salk Institute. In 2020, he moved to Immuneering Corporation as Head/Sr. Director of Neuroscience Development where he played a pivotal role in advancing two drug pipelines, and straddled business development leading to successful pharma partnerships, including an IPO exit. Later, Dr. Kagalwala co-founded Alleo Labs, an early-stage biotech company focused on developing precision medicine for CNS diseases. His research topics mainly include Alzheimer’s disease, Parkinson’s disease, and other neurological disorders over the last 19 years. Dr. Kagalwala enjoys mentoring next generation of entrepreneurs at the Basement and StartR programs at UCSD.

Elizabeth Cho-Fertikh, PhD, General Partner & Managing Director Elizabeth has 30 years cross-functional experience in drug development, regulatory affairs and clinical trials for startups, biotech & academia. She has been an active angel investor for the past decade. She is the Cofounder of MEDA Angels and a General Partner of its affiliated fund, MEDA Angels Fund I. She currently serves as a Scientific & Commercialization Advisor to the NIH’s National Cancer Institute’s Technology Transfer Office, as a reviewer of its SBIR/STTR grants and was formerly on the Investment Committee of the Health Innovation Consortium, providing investment recommendations to the VA Commonwealth Health System. Elizabeth also serves on the advisory board of healthcare startups including Playbl, Oxiwear & NuvOx Pharma and as a regulatory affairs consultant to numerous biotech & medical device companies. She received her BA from Johns Hopkins, her MS from Georgetown University, her PhD from Thomas Jefferson School of Medicine and completed her postdoctoral fellowship at Harvard Medical School & NIH.

Mash is with Alexander Hunt, a boutique investment bank that focuses on growth equity projects in the SAAS, Cyber Security, IoT, eCommerce, and B2B software industries, assisting them with Seed, Series A, Series B, and venture capital solutions. At the firm, Mash oversees Venture Solutions, the company’s consulting arm, which specializes in helping founders raise $2 million to $20 million (seed to Series A).

Dr. Roberta Lee is a general surgeon, entrepreneur and angel investor. She completed residency at the University of California, San Francisco (UCSF) and a surgical oncology fellowship at the National Cancer Institute, NIH. More recently she received an MBA with honors from Saint Mary’s College. Dr. Lee co-founded two medical device companies in breast cancer diagnostics with one exit. She has over 20 issued patents and six publications. Dr. Lee has been an angel investor with the Keiretsu Forum for the past 10 years where she is co-chair of the Northern California Life Science Committee. She is also an active member of Life Science Angels. She has led and participated in multiple due diligence teams for investors, judged at multiple pitch events, worked as a consultant for life science start-up companies and is currently CEO of Sonofii. Dr. Lee remains active in the operating room, primarily assisting in cardiac surgery operations.

Eli is Co-founder & Managing Partner of Investors of Color, a network of Black, Latinx and other underrepresented accredited investors mobilizing capital to close the racial funding gap. He is also an Investment Principal with the Gaingels Healthcare Fund. He also serves as a Principal and Capital Advisor to the Science Center Health Fund. He is an angel investor and serves on the Board of the Angel Capital Association, Hispanics in Philanthropy, and Founders First Capital.

June W Choi is founding Managing Partner of Serval Ventures, emerging tech & infrastructure venture builder and investor. With a focus on innovations leveraging data, AI, blockchain, to accelerate the velocity of transformative solutions to market with creative strategies, nurturing diverse talent, and building global relationships. Serval exited its first portfolio company in 2018, three years after launching. June is an investor, master mentor, startup advisor, entrepreneurship teacher, systems innovation strategist, experienced executive, speaker, and aggregate complex systems 4D thinker. Before launching Serval, June was a very young executive, then ran a strategy consulting firm for many years working on issues such as strategic planning, board development, financial and operational systems and processes, cultural/diversity/inclusion issues, succession planning, fundraising and investment planning, trainings, and facilitation. June also has broad understanding of nonprofit and philanthropy, extensive speaking experience, and served on numerous panels, committees, and boards.

Garrett is the founder and Managing Partner of SUM Ventures and Chairman of the Band of Angels Los Angeles. He is an entrepreneur, investor, decorated Afghan War veteran, and former USAF Captain. Before SUM Ventures he led investments for family offices, angel groups, and corporate venture funds. Garrett has served on the Board of Directors for UNest, DressX (observer), Brius, and ClearClub. He has served as an investor and advisor for Brius, DressX, UNest, Irrigreen, Automotus, Wave On, Purlin, Clear Club, and Champions Round. Garrett is passionate about helping startups succeed through SUM Ventures.

Harris Rose is a Harvard and Wharton trained physician entrepreneur who focuses on the use of technology to improve healthcare and the world. Harris began his career as a nuclear engineer and department head aboard the US Navy submarine, USS PINTADO. Following his service in the Navy, Harris went on to become an orthopedic surgeon and founded Precision Bone & Joint, an Austin, TX orthopedic surgery practice. Dr. Rose now provides technical, financial and fundraising advice to healthcare startups and is Managing Director and Chief Medical Officer at CerraCap Ventures, a venture capital firm that invests in healthcare, artificial intelligence and cybersecurity startups. Harris currently divides his time between Austin, TX and Park City, UT, where he enjoys his time with his wife of 25 years and his three children.